Optimizing heat inactivation for SARS-CoV-2 at 95 °C and its implications: A standardized approach

Standardized and validated heat inactivation procedure for Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not available. For heat inactivation, various protocols were reported to prepare External Quality Assessment Programme (EQAP) samples without direct comparison between differen...

Full description

Saved in:
Bibliographic Details
Published inHeliyon Vol. 10; no. 8; p. e28371
Main Authors Mak, Gannon C.K., Lau, Stephen S.Y., Wong, Kitty K.Y., Than, Eunice K.Y., Ng, Anita Y.Y., Hung, Derek L.L.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 30.04.2024
Elsevier
Online AccessGet full text

Cover

Loading…
More Information
Summary:Standardized and validated heat inactivation procedure for Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are not available. For heat inactivation, various protocols were reported to prepare External Quality Assessment Programme (EQAP) samples without direct comparison between different durations. To assess the heat inactivation procedures against SARS-CoV-2. The efficacy of the optimized condition was reflected by the results from laboratories testing the EQAP samples. The SARS-CoV-2 strain was exposed to 95 °C in a water bath for three different time intervals, 5 min, 10 min and 15 min, respectively. The efficacy of inactivation was confirmed by the absence of cytopathic effects and decreasing viral load in 3 successive cell line passages. The viral stock inactivated by the optimal time interval was dispatched to EQAP participants and the result returned were analyzed. All of the three conditions were capable of inactivating the SARS-CoV-2 of viral load at around cycle threshold value of 10. When the 95 °C 10 min condition was chosen to prepare SARS-CoV-2 EQAP samples, they showed sufficient homogeneity and stability. High degree of consensus was observed among EQAP participants in all samples dispatched. The conditions evaluated in the present study could be helpful for laboratories in preparing SARS-CoV-2 EQAP samples.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2405-8440
2405-8440
DOI:10.1016/j.heliyon.2024.e28371